Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 360

1.

Predicting drug-drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge.

Takeda T, Hao M, Cheng T, Bryant SH, Wang Y.

J Cheminform. 2017 Mar 7;9:16. doi: 10.1186/s13321-017-0200-8. eCollection 2017 Mar 7.

2.

Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study.

Van Den Driessche G, Fourches D.

J Cheminform. 2017 Mar 4;9:13. doi: 10.1186/s13321-017-0202-6. eCollection 2017 Mar 4.

3.

CATTLE (CAncer treatment treasury with linked evidence): An integrated knowledge base for personalized oncology research and practice.

Soysal E, Lee HJ, Zhang Y, Huang LC, Chen X, Wei Q, Zheng W, Chang JT, Cohen T, Sun J, Xu H.

CPT Pharmacometrics Syst Pharmacol. 2017 Mar;6(3):188-196. doi: 10.1002/psp4.12174. Epub 2017 Mar 13.

4.

A standard database for drug repositioning.

Brown AS, Patel CJ.

Sci Data. 2017 Mar 14;4:170029. doi: 10.1038/sdata.2017.29.

5.

Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis.

Toro-Domínguez D, Carmona-Sáez P, Alarcón-Riquelme ME.

Arthritis Res Ther. 2017 Mar 11;19(1):54. doi: 10.1186/s13075-017-1263-7.

6.

The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data.

Awale M, Reymond JL.

J Cheminform. 2017 Feb 21;9:11. doi: 10.1186/s13321-017-0199-x. eCollection 2017 Feb 21.

7.

Using Drug Similarities for Discovery of Possible Adverse Reactions.

Muñoz E, Nováček V, Vandenbussche PY.

AMIA Annu Symp Proc. 2017 Feb 10;2016:924-933. eCollection 2017 Feb 10.

8.

A Topic-modeling Based Framework for Drug-drug Interaction Classification from Biomedical Text.

Li D, Liu S, Rastegar-Mojarad M, Wang Y, Chaudhary V, Therneau T, Liu H.

AMIA Annu Symp Proc. 2017 Feb 10;2016:789-798. eCollection 2017 Feb 10.

9.

IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer.

Mounika Inavolu S, Renbarger J, Radovich M, Vasudevaraja V, Kinnebrew GH, Zhang S, Cheng L.

CPT Pharmacometrics Syst Pharmacol. 2017 Mar;6(3):168-176. doi: 10.1002/psp4.12167. Epub 2017 Mar 7.

10.

Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015.

Matsui T, Umetsu R, Kato Y, Hane Y, Sasaoka S, Motooka Y, Hatahira H, Abe J, Fukuda A, Naganuma M, Kinosada Y, Nakamura M.

Int J Med Sci. 2017 Jan 15;14(2):102-109. doi: 10.7150/ijms.17025. eCollection 2017 Jan 15.

11.

Drug voyager: a computational platform for exploring unintended drug action.

Oh M, Ahn J, Lee T, Jang G, Park C, Yoon Y.

BMC Bioinformatics. 2017 Feb 28;18(1):131. doi: 10.1186/s12859-017-1558-3.

12.

Exploring targeted therapy of osteosarcoma using proteomics data.

Chaiyawat P, Settakorn J, Sangsin A, Teeyakasem P, Klangjorhor J, Soongkhaw A, Pruksakorn D.

Onco Targets Ther. 2017 Feb 1;10:565-577. doi: 10.2147/OTT.S119993. eCollection 2017 Feb 1.

13.

Mining the Proteome of Fusobacterium nucleatum subsp. nucleatum ATCC 25586 for Potential Therapeutics Discovery: An In Silico Approach.

Habib AM, Islam MS, Sohel M, Mazumder MH, Sikder MO, Shahik SM.

Genomics Inform. 2016 Dec;14(4):255-264. doi: 10.5808/GI.2016.14.4.255. Epub 2016 Dec 30.

14.

A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant Situations.

Thiel C, Cordes H, Fabbri L, Aschmann HE, Baier V, Smit I, Atkinson F, Blank LM, Kuepfer L.

PLoS Comput Biol. 2017 Feb 2;13(2):e1005280. doi: 10.1371/journal.pcbi.1005280. eCollection 2017 Feb 2.

15.

PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.

Fohner AE, Sparreboom A, Altman RB, Klein TE.

Pharmacogenet Genomics. 2017 Apr;27(4):164-167. doi: 10.1097/FPC.0000000000000270. No abstract available.

PMID:
28146011
16.

Computational methods in drug discovery.

Leelananda SP, Lindert S.

Beilstein J Org Chem. 2016 Dec 12;12:2694-2718. doi: 10.3762/bjoc.12.267. eCollection 2016 Dec 12. Review.

17.

Multiscale modeling reveals inhibitory and stimulatory effects of caffeine on acetaminophen-induced toxicity in humans.

Thiel C, Cordes H, Baier V, Blank LM, Kuepfer L.

CPT Pharmacometrics Syst Pharmacol. 2017 Feb;6(2):136-146. doi: 10.1002/psp4.12153. Epub 2017 Jan 28.

18.

Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.

Chang CY, Wang MC, Miyagawa T, Chen ZY, Lin FH, Chen KH, Liu GS, Tseng CL.

Int J Nanomedicine. 2016 Dec 30;12:279-294. doi: 10.2147/IJN.S114754. eCollection 2016 Dec 30.

19.

Comparative interactomics for virus-human protein-protein interactions: DNA viruses versus RNA viruses.

Durmuş S, Ülgen KÖ.

FEBS Open Bio. 2017 Jan 4;7(1):96-107. doi: 10.1002/2211-5463.12167. eCollection 2017 Jan 4.

20.

Scaffold analysis of PubChem database as background for hierarchical scaffold-based visualization.

Velkoborsky J, Hoksza D.

J Cheminform. 2016 Dec 29;8:74. doi: 10.1186/s13321-016-0186-7. eCollection 2016 Dec 29.

Supplemental Content

Support Center